Suppr超能文献

显微镜下结肠炎:病因学、诊断和合理治疗。

Microscopic colitis: Etiopathology, diagnosis, and rational management.

机构信息

Department of Gastroenterology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.

Department of Gastroenterology, Hospital Universitari Mutua Terrassa, Barcelona, Spain.

出版信息

Elife. 2022 Aug 1;11:e79397. doi: 10.7554/eLife.79397.

Abstract

Microscopic colitis is an inflammatory bowel disease divided into two subtypes: collagenous colitis and lymphocytic colitis. With an increasing incidence of microscopic colitis exceeding those of ulcerative and Crohn's disease among elderly people in some countries, microscopic colitis is a debilitating life experience. Therefore, physicians should be familiar with its clinical features and management strategies because the disease deserves the same attention as the classical inflammatory bowel diseases. Here, state-of-the-art knowledge of microscopic colitis is provided from a global perspective with reference to etiopathology and how to establish the diagnosis with the overall aim to create awareness and improve rational management in clinical practice. The immune system and a dysregulated immune response seem to play a key role combined with risk factors (e.g. cigarette smoking) in genetically predisposed individuals. The symptoms are characterized by recurrent or chronic nonbloody, watery diarrhea, urgency, weight loss, and a female preponderance. As biomarkers are absent, the diagnosis relies on colonoscopy with a histological assessment of biopsy specimens from all parts of the colon. Although the disease is not associated with a risk of colorectal cancer, a recent nationwide, population-based cohort study found an increased risk of lymphoma and lung cancer. Budesonide is the first-line therapy for management, whereas immunomodulatory drugs (including biologics) and drugs with antidiarrheal properties may be indicated in those failing, dependent, or intolerant to budesonide. In microscopic colitis induced by checkpoint inhibitors, a drug class used increasingly for a wide range of malignancies, a more aggressive therapeutic approach with biologics introduced early seems reasonable. However, particular attention needs to be drawn to the existence of incomplete forms of microscopic colitis with the risk of being overlooked in routine clinical settings.

摘要

显微镜下结肠炎是一种炎症性肠病,分为两个亚型:胶原性结肠炎和淋巴细胞性结肠炎。在一些国家,老年人中显微镜下结肠炎的发病率超过溃疡性结肠炎和克罗恩病,显微镜下结肠炎是一种使人衰弱的生活体验。因此,医生应该熟悉其临床特征和管理策略,因为这种疾病应该得到与经典炎症性肠病同样的重视。本文从全球角度提供了显微镜下结肠炎的最新知识,参考了发病机制,并介绍了如何通过整体诊断来建立诊断,旨在提高临床实践中的认识和合理管理。免疫系统和失调的免疫反应似乎与遗传易感性个体的危险因素(如吸烟)共同发挥关键作用。症状表现为反复发作或慢性非血性、水样腹泻、急迫感、体重减轻和女性患病率较高。由于缺乏生物标志物,诊断依赖于结肠镜检查,并对结肠各部位的活检标本进行组织学评估。尽管该疾病与结直肠癌风险无关,但最近一项全国性、基于人群的队列研究发现,淋巴瘤和肺癌的风险增加。布地奈德是治疗的一线药物,而免疫调节剂(包括生物制剂)和具有抗腹泻作用的药物可能适用于那些对布地奈德无效、依赖或不耐受的患者。在由检查点抑制剂引起的显微镜下结肠炎中,由于这类药物被越来越多地用于广泛的恶性肿瘤,因此早期使用生物制剂进行更积极的治疗方法似乎是合理的。然而,需要特别注意不完全形式的显微镜下结肠炎的存在,因为在常规临床环境中可能会被忽视。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5e6/9342949/ff8c5891c9e7/elife-79397-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验